Search Contract Opportunities

Midazolam Autoinjectors Project Bioshield   3

ID: 75A50121R00003 • Type: Solicitation

Description

This Request for Proposal (RFP) covers the advanced research and development, procurement, and delivery of adult and pediatric midazolam autoinjectors that have received FDA approval for the treatment of status epilepticus seizures (including seizures caused by nerve agents) in adult and pediatric populations (2+ years of age).

Please see attached RFP for additional details.

Background
The contract is for the advanced research and development, procurement, and delivery of adult and pediatric midazolam autoinjectors that have received FDA approval for the treatment of status epilepticus seizures in adult and pediatric populations. The project falls under the Midazolam Autoinjectors Project Bioshield.

Work Details
The work includes the development, procurement, and delivery of midazolam autoinjectors for the treatment of status epilepticus seizures caused by nerve agents in both adult and pediatric populations aged 2 years and above. The contractor will be responsible for advanced research and development as well as ensuring FDA approval for the autoinjectors. The RFP document attached provides additional details on the specific tasks and services to be completed under this contract.
Show All

Overview

Agency
HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) [HHS]
Response Deadline
July 30, 2021, 4:00 p.m. EDT (original: July 19, 2021, 4:00 p.m. EDT) Past Due
Posted
June 17, 2021, 12:39 p.m. EDT (updated: July 15, 2021, 6:00 p.m. EDT)
Set Aside
None
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN11 - Health R&D Services; Health Care Services; Basic Research
Place of Performance
Not Provided
Source
SAM
Current SBA Size Standard
1000 Employees
Pricing
Fixed Price; Cost Plus Fixed Fee;
Evaluation Criteria
Best Value
Est. Level of Competition
High
On 6/17/21 HHS Office of the Assistant Secretary for Preparedness and Response issued Solicitation 75A50121R00003 for Midazolam Autoinjectors Project Bioshield due 7/30/21. The opportunity was issued full & open with NAICS 541714 and PSC AN11.
Primary Contact
Name
Jill Johnson, Contracting Officer   Profile
Email
jill.johnson@hhs.gov
Phone
(202) 816-1148

Secondary Contact

Name
Kevin Restrepo, Contract Specialist   Profile
Email
kevin.restrepo@hhs.gov
Phone
(202) 815-2367

Documents

Posted documents for Solicitation 75A50121R00003

Question & Answer

Opportunity Lifecycle

Procurement notices related to Solicitation 75A50121R00003

Contract Awards

Prime contracts awarded through Solicitation 75A50121R00003

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation 75A50121R00003

Similar Active Opportunities

Open contract opportunities similar to Solicitation 75A50121R00003

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE > ASPR BARDA DIV CONTRACTS MGMT & ACQ
FPDS Organization Code
7505-75ANBA
Source Organization Code
500155218
Last Updated
Aug. 14, 2021
Last Updated By
kevin.restrepo@hhs.gov
Archive Date
Aug. 14, 2021